Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Papillomavirus Infections | 12 | 2025 | 376 | 4.190 |
Why?
|
| Anus Neoplasms | 4 | 2025 | 44 | 2.650 |
Why?
|
| Papillomaviridae | 6 | 2025 | 142 | 2.420 |
Why?
|
| Puerto Rico | 24 | 2025 | 1413 | 2.190 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2024 | 367 | 1.410 |
Why?
|
| HIV Infections | 5 | 2025 | 2586 | 1.110 |
Why?
|
| Early Detection of Cancer | 5 | 2023 | 449 | 0.990 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2025 | 989 | 0.910 |
Why?
|
| Cervix Uteri | 2 | 2017 | 48 | 0.880 |
Why?
|
| Papillomavirus Vaccines | 2 | 2025 | 174 | 0.870 |
Why?
|
| Cross-Sectional Studies | 10 | 2025 | 3156 | 0.770 |
Why?
|
| Adult | 20 | 2025 | 13872 | 0.740 |
Why?
|
| Middle Aged | 17 | 2025 | 12222 | 0.710 |
Why?
|
| Female | 23 | 2025 | 24698 | 0.690 |
Why?
|
| Vaginal Smears | 2 | 2012 | 63 | 0.690 |
Why?
|
| Antibodies, Viral | 2 | 2025 | 306 | 0.660 |
Why?
|
| Young Adult | 13 | 2025 | 5080 | 0.660 |
Why?
|
| Adolescent | 11 | 2025 | 6081 | 0.600 |
Why?
|
| Risk Factors | 9 | 2025 | 3994 | 0.590 |
Why?
|
| Video Recording | 1 | 2019 | 41 | 0.590 |
Why?
|
| Anus Diseases | 2 | 2016 | 17 | 0.590 |
Why?
|
| Mouth | 2 | 2019 | 54 | 0.560 |
Why?
|
| Humans | 25 | 2025 | 43102 | 0.550 |
Why?
|
| Alphapapillomavirus | 2 | 2014 | 31 | 0.540 |
Why?
|
| Periodontitis | 1 | 2018 | 62 | 0.520 |
Why?
|
| Anal Canal | 2 | 2019 | 32 | 0.520 |
Why?
|
| Neoplasms | 2 | 2020 | 1377 | 0.490 |
Why?
|
| Genotype | 2 | 2016 | 800 | 0.480 |
Why?
|
| Vaccination | 1 | 2018 | 355 | 0.460 |
Why?
|
| Stomatitis | 1 | 2014 | 2 | 0.450 |
Why?
|
| Gastroenterology | 1 | 2013 | 8 | 0.410 |
Why?
|
| Medical Oncology | 1 | 2013 | 50 | 0.400 |
Why?
|
| Incidence | 4 | 2024 | 1078 | 0.390 |
Why?
|
| Health Promotion | 1 | 2019 | 704 | 0.380 |
Why?
|
| Self Administration | 1 | 2013 | 69 | 0.380 |
Why?
|
| Specimen Handling | 1 | 2013 | 63 | 0.380 |
Why?
|
| Seroepidemiologic Studies | 2 | 2025 | 74 | 0.370 |
Why?
|
| Ambulatory Care | 1 | 2013 | 81 | 0.370 |
Why?
|
| Education, Medical | 1 | 2013 | 118 | 0.370 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2014 | 226 | 0.360 |
Why?
|
| Liver Diseases | 1 | 2011 | 34 | 0.350 |
Why?
|
| Registries | 3 | 2024 | 437 | 0.350 |
Why?
|
| Self Care | 1 | 2012 | 175 | 0.340 |
Why?
|
| Genetic Testing | 1 | 2011 | 91 | 0.330 |
Why?
|
| Diabetes Complications | 1 | 2011 | 102 | 0.330 |
Why?
|
| Prevalence | 5 | 2019 | 1612 | 0.330 |
Why?
|
| Uterine Neoplasms | 1 | 2012 | 53 | 0.330 |
Why?
|
| Male | 11 | 2025 | 23409 | 0.320 |
Why?
|
| Breast Neoplasms | 2 | 2013 | 1723 | 0.320 |
Why?
|
| DNA, Viral | 3 | 2017 | 311 | 0.300 |
Why?
|
| Endometrial Neoplasms | 1 | 2010 | 79 | 0.290 |
Why?
|
| Liver Neoplasms | 1 | 2011 | 224 | 0.290 |
Why?
|
| Mass Screening | 1 | 2012 | 541 | 0.280 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2012 | 497 | 0.270 |
Why?
|
| Aged | 6 | 2024 | 8214 | 0.260 |
Why?
|
| Substance-Related Disorders | 1 | 2014 | 830 | 0.250 |
Why?
|
| Odds Ratio | 2 | 2018 | 587 | 0.240 |
Why?
|
| Homosexuality, Male | 2 | 2023 | 486 | 0.240 |
Why?
|
| Cost of Illness | 2 | 2017 | 98 | 0.230 |
Why?
|
| Logistic Models | 2 | 2018 | 1009 | 0.220 |
Why?
|
| Sex Factors | 3 | 2018 | 1028 | 0.210 |
Why?
|
| Neoplasm Staging | 1 | 2024 | 374 | 0.200 |
Why?
|
| Age Factors | 3 | 2018 | 1154 | 0.190 |
Why?
|
| United States | 3 | 2021 | 5205 | 0.190 |
Why?
|
| Survival Analysis | 2 | 2014 | 368 | 0.190 |
Why?
|
| Comorbidity | 2 | 2014 | 737 | 0.180 |
Why?
|
| SEER Program | 2 | 2012 | 164 | 0.160 |
Why?
|
| Genitalia, Male | 1 | 2019 | 14 | 0.150 |
Why?
|
| Human papillomavirus 6 | 1 | 2018 | 1 | 0.140 |
Why?
|
| Human papillomavirus 11 | 1 | 2018 | 2 | 0.140 |
Why?
|
| Human papillomavirus 18 | 1 | 2018 | 6 | 0.140 |
Why?
|
| Human papillomavirus 16 | 1 | 2018 | 37 | 0.140 |
Why?
|
| Condylomata Acuminata | 1 | 2017 | 6 | 0.130 |
Why?
|
| Program Evaluation | 1 | 2019 | 359 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 458 | 0.120 |
Why?
|
| Sampling Studies | 1 | 2014 | 64 | 0.110 |
Why?
|
| Prediabetic State | 1 | 2016 | 69 | 0.110 |
Why?
|
| Interviews as Topic | 1 | 2016 | 452 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1063 | 0.110 |
Why?
|
| Sentinel Surveillance | 1 | 2014 | 25 | 0.110 |
Why?
|
| Sexual Partners | 1 | 2017 | 326 | 0.100 |
Why?
|
| Warts | 1 | 2013 | 5 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2012 | 2853 | 0.100 |
Why?
|
| Socioeconomic Factors | 2 | 2016 | 1234 | 0.100 |
Why?
|
| Education, Medical, Continuing | 1 | 2013 | 35 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2010 | 2544 | 0.100 |
Why?
|
| Uterine Cervical Diseases | 1 | 2013 | 14 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 238 | 0.100 |
Why?
|
| HIV Seropositivity | 1 | 2014 | 196 | 0.100 |
Why?
|
| Educational Measurement | 1 | 2013 | 102 | 0.100 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 116 | 0.100 |
Why?
|
| Prisoners | 1 | 2014 | 102 | 0.100 |
Why?
|
| Receptors, Progesterone | 1 | 2013 | 92 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2013 | 146 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 183 | 0.090 |
Why?
|
| Probability | 1 | 2012 | 82 | 0.090 |
Why?
|
| Biotechnology | 1 | 2011 | 15 | 0.090 |
Why?
|
| Physicians | 1 | 2013 | 188 | 0.090 |
Why?
|
| Students, Medical | 1 | 2013 | 158 | 0.090 |
Why?
|
| Consumer Health Information | 1 | 2011 | 24 | 0.090 |
Why?
|
| Marketing | 1 | 2011 | 45 | 0.090 |
Why?
|
| Alcoholism | 1 | 2014 | 305 | 0.080 |
Why?
|
| Prognosis | 1 | 2013 | 861 | 0.080 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 539 | 0.080 |
Why?
|
| Sexual Behavior | 1 | 2014 | 638 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 235 | 0.080 |
Why?
|
| Quality of Life | 1 | 2014 | 616 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 638 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2014 | 661 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2011 | 549 | 0.070 |
Why?
|
| Body Weights and Measures | 1 | 2016 | 25 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2016 | 389 | 0.030 |
Why?
|
| Life Style | 1 | 2016 | 334 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 780 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2016 | 666 | 0.020 |
Why?
|
| Health Behavior | 1 | 2016 | 575 | 0.020 |
Why?
|